Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001837607-25-000007
Filing Date
2025-01-23
Accepted
2025-01-23 16:45:44
Documents
4
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A aeon-20250224xdef14a.htm DEF 14A 315254
2 GRAPHIC aeon-20250224xdef14a_a002.jpg GRAPHIC 12224
3 GRAPHIC aeon-20250224xdef14a_bg001.jpg GRAPHIC 145319
4 GRAPHIC aeon-20250224xdef14a_bg002.jpg GRAPHIC 90231
  Complete submission text file 0001837607-25-000007.txt   650270
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40021 | Film No.: 25550696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)